Johnson and Johnson’s Attune Knee System shows value in new report

Johnson and Johnson has announced the publication of a new report showing the value offered by its Attune Knee System.

Created by its subsidiary DePuy Synthes, the device's clinical and economic benefits were recently evaluated in a study authored by the medical experts Dr David Fisher and Professor David Parkin.

It assessed approaches for evaluating primary total knee arthroplasty (TKA) from a clinical and health economics perspective, finding that Attune provides advantages for medical professionals, patients and those funding the system alike.

The report also noted that in a value-based healthcare environment constrained by costs and growing procedure volumes, the value of an implant should be measured not only by how long the implant lasts, but also through patient-reported outcomes and the economic benefits of the procedure.

It concluded: "Based on available data, the Attune Knee appears to be advancing outcomes for patients and creating value for clinicians, providers and payors in a challenging and dynamic healthcare environment."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.